SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors debate the impact of the company's aggressive Bitcoin accumulation strategy, which remains a polarizing topic amid recent price volatility. The community is sharply divided between those who view the firm as a high-conviction leveraged play on Bitcoin and critics who express concerns over ongoing share dilution and the stock's sensitivity to broader market risks.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility as retail investors debate whether current price levels represent a significant buying opportunity or a deeper correction fueled by broader market uncertainty and geopolitical concerns. While some in the community are actively organizing around the potential for a short squeeze due to high short interest and borrowing costs, others remain focused on the company's long-term enterprise growth and recent industry recognition.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense buzz as investors anticipate high-impact long-term efficacy data from the VELA Phase 3 trials at the upcoming American Academy of Dermatology conference. Community sentiment remains highly bullish, with many participants citing the potential for the drug to be classified as 'best-in-class' and speculating on an inevitable buyout by Big Pharma as institutional interest continues to mount.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors focus on the upcoming earnings report and the expected filing of the annual 10-K, with the community closely tracking debt reduction efforts and potential value realization from core holdings like BW. Sentiment remains highly polarized as supporters anticipate a structural turnaround and short squeeze, while others remain cautious due to recent filing delays and ongoing volatility.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is experiencing intense volatility and speculative interest from retail traders drawn to its unique community-owned, share-based shopping model. The community is actively debating the stock's potential for massive momentum-driven squeezes due to its low float and high borrow rates, while skeptics express concern over its lack of substantial revenue and potential for a rapid rug-pull.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending following the FDA approval of EMPAVELI for rare kidney diseases, a long-awaited catalyst that de-risks the company and strengthens its nephrology portfolio. The community is actively debating the stock's future, balancing optimism over this label expansion and upcoming earnings with lingering frustration regarding management's past execution and previous revenue guidance challenges.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point of intense community debate, driven by a mix of long-term sentiment among holders banking on institutional tokenization and a vocal group of traders focused on recent volatility and all-time low price points. Discussions are currently centered on the impact of a newly constituted Board of Directors and the project's pivot toward U.S. operations, with the community split between those accumulating 

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as traders closely monitor escalating geopolitical tensions in the Middle East and conflicting reports regarding potential ceasefires. The community is actively debating the impact of disrupted shipping routes through the Strait of Hormuz, with many users focused on the divergence between official diplomatic messaging and the reality of persistent energy supply risks.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as traders debate the sustainability of recent rallies in the chip sector amidst heightened geopolitical uncertainty and oil market volatility. Community discourse is sharply divided between those positioning for a long-term semiconductor correction and those cautioning against holding structurally decaying inverse ETFs, especially as high-profile announcements from the AI space continue to fuel sentiment shifts.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil (UCO) is seeing intense volatility as investors weigh the potential for a severe energy supply shock amid the ongoing conflict in the Middle East and the closure of the Strait of Hormuz. The community is actively debating whether current price action reflects genuine geopolitical risk or market manipulation, with many traders focusing on the high-stakes battle between long-term supply concerns and rapid government interventions like strategic reserve releases.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMZN expect 218-224$ range for earning end of April. (232 high 212 low) beat &amp; positive guidance should bring back 250$ range with room to run

StockTwits for iOS

Amazon.com Inc

 expect 218-224$ range for earning end of April. (232 high 212 low) beat & positive guidance should bring back 250$ range with room to run